S E McArdle

Summary

Affiliation: Nottingham Trent University
Country: UK

Publications

  1. ncbi Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant
    S E McArdle
    Division of Oncology and Cellular Pathology Cancer Studies, University of Sheffield Medical School, UK
    Cancer Immunol Immunother 49:417-25. 2000
  2. ncbi Cancer vaccines: Uses of HLA transgenic mice compared to genetically modified mice
    Stephanie McArdle
    The John Van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS Nottingham
    Front Biosci 14:4640-51. 2009
  3. ncbi Tumor immunology: new perspectives
    Stephanie E McArdle
    The John Van Geest Cancer Research Centre, Nottingham Trent University, School of Science and Technology, Nottingham, United Kingdom
    Cancer Res 69:7157-9. 2009
  4. ncbi CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model
    S A Ali
    School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK
    Parasite Immunol 31:373-83. 2009

Detail Information

Publications4

  1. ncbi Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant
    S E McArdle
    Division of Oncology and Cellular Pathology Cancer Studies, University of Sheffield Medical School, UK
    Cancer Immunol Immunother 49:417-25. 2000
    ..This suggests that these peptides are presented on the surface of SaOs-2/175 and SKBr3-A2 cells in a conformation-dependent manner and represent potentially useful target peptides for immunotherapy...
  2. ncbi Cancer vaccines: Uses of HLA transgenic mice compared to genetically modified mice
    Stephanie McArdle
    The John Van Geest Cancer Research Centre, School of Science and Technology, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS Nottingham
    Front Biosci 14:4640-51. 2009
    ..In this review, mice genetically modified to express HLA genes or to spontaneously develop tumors are discussed, highlighting their advantages and limitations as preclinical models for cancer immunotherapy...
  3. ncbi Tumor immunology: new perspectives
    Stephanie E McArdle
    The John Van Geest Cancer Research Centre, Nottingham Trent University, School of Science and Technology, Nottingham, United Kingdom
    Cancer Res 69:7157-9. 2009
    ....
  4. ncbi CTL responses to Leishmania mexicana gp63-cDNA vaccine in a murine model
    S A Ali
    School of Science and Technology, Nottingham Trent University, Clifton, Nottingham, UK
    Parasite Immunol 31:373-83. 2009
    ..mexicana gp63 cDNA or SLA and long-lived CTL activity was observed in immunized and/or re-challenged mice but not naïve mice infected with the parasite...